Navigation Links
Plandai Biotechnology, Inc. Updates Progress Of Preparing Products For Market
Date:4/8/2013

SEATTLE, April 8, 2013 /PRNewswire/ -- Plandai Biotechnology, Inc., (OTCQB: PLPL) a producer of highly bioavailable plant extracts, today provided an update to shareholders of recent progress in preparing its products for market.

Plandai Chief Executive Officer Roger Duffield stated, "The past few months, while quiet from a press standpoint, have been extremely active for Plandai.  At the top of the list, our South African subsidiary, Breakwood Trading 22, has rehabilitated over 500 acres of green tea bushes on its 8,000 acres estate.  Our goal has been to have 800 acres prepared in time for the first harvest this fall, so we are ahead of schedule.  This amount of production will yield 6,000 kilos of our Phytofare™ Green Tea extract, which should be adequate for our forecasted 2014 sales."

"The tea estate rehabilitation has involved extensive infrastructure deployment in addition to pruning and weeding of the tea plants," Mr. Duffield continued.  "We needed to rebuild many of the roads and bridges and then refurbish the housing and other production buildings on site.  As a committed "green" company, all worker housing has been fitted with solar power, and water comes from our on-site reservoir.  There are currently 300 full-time workers living on the plantation helping to ensure that we meet our initial goals, with this number increasing to 500 workers when the tea harvesting begins."

In addition to progress on the tea estate, Plandai's other South African subsidiary, Green Gold Biotechnology, has been working to ready the manufacturing equipment and facility so that extract production can commence in time for the first harvest.  Mr. Duffield added, "Green Gold is our business that is tasked with producing the extract from the live botanical material. The on-site factory is nearing completion and the equipment, which is being custom built in India, is in the final stages of testing.  We expect to ship the equipment in April and have the factory commissioned by August 2013." 

"Short term," Mr. Duffield concluded, "we need to commence production of our Phytofare™ extracts and begin selling.  To this end, we have finished with our product profiling and are aggressively working towards having our full-scale production operational by the end of the year."

About Plandai Biotechnology, Inc.

Plandai Biotechnology, Inc. and its subsidiaries, focus on the farming of whole fruits, vegetables and live plant material and the production of proprietary functional foods and botanical extracts for the health and wellness industry.  Its principle holdings consist of land, farms and infrastructure in South Africa.

Safe Harbor Statement

The information provided may contain forward-looking statements and involve risks and uncertainties. Results, events and performances could vary from those contemplated. These statements involve risks and uncertainties which may cause actual results, expressed or implied, to differ from predicted outcomes. Risks and uncertainties include product demand, market competition, and Plandai's ability to meet current or future plans. Investors should study and understand all risks before making an investment decision. Readers are recommended not to place undue reliance on forward-looking statements or information. Plandai is not obliged to publicly release revisions to any forward-looking statement, to reflect events or circumstances afterward, or to disclose unanticipated occurrences, except as required under applicable laws.

Contact: 
Andrew Beyer
Phone: 619-202-7456
Email:  investors@Plandaibiotech.com

 


'/>"/>
SOURCE Plandai Biotechnology, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. DuPont Pioneer and Mendel Biotechnology, Inc. Collaborate to Improve Water Use Efficiency and Photosynthesis in Corn
2. Patheon to Present New Updates in Drug Formulation and Bioavailability
3. RURO Updates FreezerPro® to Version 6
4. NSG Precision Cells Has Updated its Fluorescence Cell Line with New Updates
5. Array BioPharma Provides Updates On Clinical Data At The 2012 American Society Of Hematology Meeting
6. Medical Marijuana, Inc. Portfolio Company CanChew BioTechnologies Inc. Updates and Expands Free Product Trial
7. Correction: Amarantus BioSciences Updates Shareholders on Timing of Michael J. Fox Foundation Grant Data Release
8. Amarantus BioSciences Updates Shareholders on Timing of Michael J. Fox Foundation Grant Data Release
9. AquaLiv Technologies, Inc. and Its Subsidiary, AquaLiv, Inc., Release Funding Updates
10. Dr. Alan Gaby to Present Nutritional Medicine Updates in a Nationwide Tour
11. SPO Updates Shareholders on 2012 Corporate Strategy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... October 11, 2017 , ... ... today it will be hosting a Webinar titled, “Pathology is going digital. Is ... , on digital pathology adoption best practices and how Proscia improves lab economics ...
(Date:10/11/2017)... ... October 11, 2017 , ... ... implantation and pregnancy rates in frozen and fresh in vitro fertilization (IVF) ... and maternal age to IVF success. , After comparing the results from the ...
(Date:10/10/2017)... ... 10, 2017 , ... For the second time in three ... Mentoring Award. Representatives of the FirstHand program travelled to Washington, D.C. Tuesday, October ... US2020’s mission is to change the trajectory of STEM education in America by ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... optimization firm for the life sciences and healthcare industries, announces a presentation by ... Francisco. , The presentation, “Automating GxP Validation for Agile Cloud Platforms,” will present ...
Breaking Biology Technology:
(Date:4/13/2017)... According to a new market research report "Consumer ... Administration, and Authorization), Service, Authentication Type, Deployment Mode, Vertical, and Region - ... to grow from USD 14.30 Billion in 2017 to USD 31.75 Billion ... ... MarketsandMarkets Logo ...
(Date:4/11/2017)... Research and Markets has announced the addition of the ... ... grow at a CAGR of 30.37% during the period 2017-2021. ... prepared based on an in-depth market analysis with inputs from industry ... over the coming years. The report also includes a discussion of ...
(Date:4/11/2017)... April 11, 2017 NXT-ID, Inc. (NASDAQ: ... company, announces the appointment of independent Directors Mr. Robin ... its Board of Directors, furthering the company,s corporate governance and ... Gino Pereira ... look forward to their guidance and benefiting from their considerable ...
Breaking Biology News(10 mins):